• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Jumps Over 500 Points; Home Depot Earnings Top Views

    11/14/23 3:10:27 PM ET
    $AUVI
    $BCDA
    $HD
    $INVO
    Building Products
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $AUVI alert in real time by email

    U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 500 points on Tuesday.

    The Dow traded up 1.60% to 34,885.58 while the NASDAQ rose 2.50% to 14,111.61. The S&P 500 also rose, gaining, 2.06% to 4,502.40.

    Check This Out: Top 4 Risk Off Stocks You'll Regret Missing In Q4

     

    Leading and Lagging Sectors

     

    Real estate shares surged by 5% on Tuesday.

    In trading on Tuesday, energy shares rose by just 0.5%.

     

    Top Headline

     

    Home Depot Inc (NYSE:HD) reported better-than-expected third-quarter results.

    Home Depot reported a FY23 sales decline of 3% year-on-year to $37.71 billion, beating the analyst consensus estimate of $35.66 billion. EPS of $3.81 beat the analyst consensus of $3.58.

     

    Equities Trading UP

     

    BioCardia, Inc. (NASDAQ:BCDA) shares shot up 168% to $1.0708 after the company announced the FDA approval of its Phase 3 clinical trial of its CardiAMP autologous cell therapy for the treatment of patients with ischemic heart failure.

    Shares of INVO Bioscience, Inc. (NASDAQ:INVO) got a boost, shooting 27% to $2.05 after the company posted a narrower loss for the third quarter.

    Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) shares were also up, gaining 50% to $3.20 after the company announced process to explore strategic alternatives.

     

    Equities Trading DOWN

     

    The Beauty Health Company (NASDAQ:SKIN) shares dropped 61% to $1.5350 after the company reported weaker-than-expected financial results for its third quarter and revised its net sales outlook. Also, the company suspended its long-term full-year 2025 forecast.

    Shares of Kubient, Inc. (NASDAQ:KBNT) were down 50% to $0.1096. Kubient announced voluntary delisting from Nasdaq Capital Market.

    Applied UV, Inc. (NASDAQ:AUVI) was down, falling 44% to $0.1507. Applied UV announced pricing of $6.4 million upsized underwritten public offering of 42,666,666 units at $0.15 per unit.

    Also Check This Out: Oracle, Qualcomm And 2 Other Stocks Insiders Are Selling

     

    Commodities

     

    In commodity news, oil traded up 0.1% to $78.35 while gold traded up 0.8% at $1,966.30.

    Silver traded up 3.5% to $23.14 on Tuesday while copper rose 0.4% to $3.6820.

     

    Euro zone

     

    European shares closed higher today. The eurozone’s STOXX 600 gained 1.34%, London’s FTSE 100 rose 0.20% while Spain’s IBEX 35 Index rose 1.71% The German DAX rose 1.76% French CAC 40 rose 1.39%, while Italy’s FTSE MIB Index climbed 1.45%.

    The ZEW Indicator of Economic Sentiment for the Eurozone surged to 13.8 in November versus 2.3 in the previous month. The GDP in the Eurozone contracted 0.1% on quarter during the three months to September, while number of employed persons increased by 0.3% to 168.7 million people during the same period.

    The ZEW Indicator of Economic Sentiment for Germany climbed by 10.9 points to a reading of +9.8 in November, while Spanish annual consumer price inflation was confirmed at 3.5% for October. The number of job vacancies in the UK fell to 957,000 in August to October. Average weekly earnings, including bonuses in the UK, rose 7.9% year-over-year to GBP 673 per week while unemployment rate came in at 4.2% in the third quarter.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Tuesday, with Japan’s Nikkei 225 rising 0.34%, Hong Kong’s Hang Seng Index falling 0.17% and China’s Shanghai Composite Index gaining 0.31%.

    Indian wholesale prices fell by 0.52% year-over-year in October versus market expectations of a 0.2% decline.

     

    Economics

     

    The annual inflation rate in the U.S. eased to 3.2% in October versus 3.7% in both September and August, and compared to market estimates of 3.3%.

    Now Read This: Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday

    Get the next $AUVI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AUVI
    $BCDA
    $HD
    $INVO

    CompanyDatePrice TargetRatingAnalyst
    Home Depot Inc.
    $HD
    12/10/2025$430.00 → $410.00Outperform
    Telsey Advisory Group
    Home Depot Inc.
    $HD
    11/19/2025$455.00 → $430.00Outperform
    Telsey Advisory Group
    Home Depot Inc.
    $HD
    11/14/2025Buy → Hold
    Stifel
    The Beauty Health Company
    $SKIN
    9/19/2025$3.50Buy
    Roth Capital
    Home Depot Inc.
    $HD
    9/18/2025$497.00Outperform
    Wolfe Research
    Home Depot Inc.
    $HD
    5/21/2025$425.00Hold → Buy
    Stifel
    Home Depot Inc.
    $HD
    4/4/2025Buy → Hold
    Gordon Haskett
    Home Depot Inc.
    $HD
    2/26/2025$356.00 → $410.00Reduce → Hold
    HSBC Securities
    More analyst ratings

    $AUVI
    $BCDA
    $HD
    $INVO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Altman Peter bought $5,650 worth of shares (5,000 units at $1.13), increasing direct ownership by 2% to 273,866 units (SEC Form 4)

    4 - BioCardia, Inc. (0000925741) (Issuer)

    2/4/26 5:47:41 PM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by EVP - Human Resources Smith Stephanie

    4 - HOME DEPOT, INC. (0000354950) (Issuer)

    2/3/26 5:11:25 PM ET
    $HD
    RETAIL: Building Materials
    Consumer Discretionary

    SEC Form 4 filed by EVP - Supply Chain & Prod. Dev Deaton John A.

    4 - HOME DEPOT, INC. (0000354950) (Issuer)

    2/3/26 5:09:59 PM ET
    $HD
    RETAIL: Building Materials
    Consumer Discretionary

    $AUVI
    $BCDA
    $HD
    $INVO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BioCardia Files Pre-Submission for FDA Approval of Helix™ Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart

    SUNNYVALE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported it has completed its Pre-Submission to FDA under its Q-Submission program for the approval of its Helix Transendocardial Delivery Catheter ("Helix") for intramyocardial therapeutic and diagnostic agent delivery.    The data supporting safety and effectiveness for the Helix Pre-Submission is from fifteen well-controlled clinical trials of cell and gene therapy delivery to the heart using Helix, where patients were enrolled in three primary cardiac clinical indications. The Helix

    2/10/26 9:15:00 AM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    The Home Depot to Host Fourth Quarter & Fiscal Year Earnings Conference Call on February 24

    ATLANTA, Feb. 10, 2026 /PRNewswire/ -- The Home Depot®, the world's largest home improvement retailer, announced today that it will hold its Fourth Quarter & Fiscal Year Earnings Conference Call on Tuesday, February 24, at 9 a.m. ET. A webcast will be available by logging onto http://ir.homedepot.com/events-and-presentations and selecting the Fourth Quarter Earnings Conference Call icon or directly at https://event.choruscall.com/mediaframe/webcast.html?webcastid=hLub2smn. The webcast will be archived, and the replay will be available beginning at approximately noon on Februar

    2/10/26 8:00:00 AM ET
    $HD
    RETAIL: Building Materials
    Consumer Discretionary

    BioCardia Announces Late Breaking Echocardiography Results from the CardiAMP HF Trial to be Presented at Technology and Heart Failure Therapeutics (THT)

    SUNNYVALE, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced echocardiography data for the CardiAMP Cell Therapy for the treatment of heart failure has been accepted for Late Breaking Clinical Trial Oral Presentation at the Technology and Heart Failure Therapeutics (THT) Meeting, which takes place March 2-4 in Boston, Massachusetts. On behalf of the CardiAMP HF investigators, the presentation will be made by Dr. Amish Raval, M.D., Professor of Medicine at UW School of Medicine and Public Health and CardiAMP HF Trial National Co-Principal

    2/3/26 8:00:00 AM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AUVI
    $BCDA
    $HD
    $INVO
    SEC Filings

    View All

    BioCardia Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - BioCardia, Inc. (0000925741) (Filer)

    2/10/26 9:15:23 AM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by The Beauty Health Company

    SCHEDULE 13G/A - Beauty Health Co (0001818093) (Subject)

    2/6/26 9:58:03 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BioCardia Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - BioCardia, Inc. (0000925741) (Filer)

    2/3/26 8:00:08 AM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AUVI
    $BCDA
    $HD
    $INVO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on Home Depot with a new price target

    Telsey Advisory Group reiterated coverage of Home Depot with a rating of Outperform and set a new price target of $410.00 from $430.00 previously

    12/10/25 8:00:40 AM ET
    $HD
    RETAIL: Building Materials
    Consumer Discretionary

    Telsey Advisory Group reiterated coverage on Home Depot with a new price target

    Telsey Advisory Group reiterated coverage of Home Depot with a rating of Outperform and set a new price target of $430.00 from $455.00 previously

    11/19/25 8:38:37 AM ET
    $HD
    RETAIL: Building Materials
    Consumer Discretionary

    Home Depot downgraded by Stifel

    Stifel downgraded Home Depot from Buy to Hold

    11/14/25 9:53:04 AM ET
    $HD
    RETAIL: Building Materials
    Consumer Discretionary

    $AUVI
    $BCDA
    $HD
    $INVO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Altman Peter bought $5,650 worth of shares (5,000 units at $1.13), increasing direct ownership by 2% to 273,866 units (SEC Form 4)

    4 - BioCardia, Inc. (0000925741) (Issuer)

    2/4/26 5:47:41 PM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    President and CEO Altman Peter bought $1,194 worth of shares (900 units at $1.33), increasing direct ownership by 0.34% to 268,866 units (SEC Form 4)

    4 - BioCardia, Inc. (0000925741) (Issuer)

    1/21/26 5:03:15 PM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    President and CEO Altman Peter bought $1,444 worth of shares (1,100 units at $1.31), increasing direct ownership by 0.41% to 267,966 units (SEC Form 4)

    4 - BioCardia, Inc. (0000925741) (Issuer)

    12/17/25 6:32:43 PM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AUVI
    $BCDA
    $HD
    $INVO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 4:16:27 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 11:27:23 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 11:03:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $AUVI
    $BCDA
    $HD
    $INVO
    Leadership Updates

    Live Leadership Updates

    View All

    BioCardia Strengthens Leadership Team with The Addition of Farhan Shahab as Vice President of Quality

    SUNNYVALE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ:BCDA), a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces the appointment of Farhan Shahab as Vice President of Quality. Mr. Shahab brings over 25 years of experience to BioCardia in similar executive roles. Mr. Shahab joins BioCardia from Welldoc (a digital health company focused on chronic disease management), where he served as Vice President of Quality and Regulatory. Prior to that, he served as Senior Director of Regulatory Affairs and Quality Assurance at Intuity Medical (a blood glucose monitoring device company), and as Dir

    11/24/25 8:15:00 AM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors

    LONG BEACH, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of global aesthetics leader, Philippe Schaison, PharmaD, to its Board of Directors, effective as of October 30, 2025. Dr. Schaison has spent over 20 years leading organizations across the global aesthetics, biotech, and consumer health industries. He currently serves as Chief Executive Officer and a director of Soltégo, Inc., a bio-cosmetic company. Previously, Dr. Schaison was Chief Executive Officer NA of Syneron Candela, President of Allergan Aesthetics, and held senior leadership roles at Clarins, Johnson & Johnson, and L'Oré

    11/3/25 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company Names Pedro Malha President and Chief Executive Officer

    Global Healthcare and Medical Device Executive with More Than 20 Years of Experience Assumes Role Effective October 1 Marla Beck Steps Down, With BeautyHealth Prepared for Its Next Phase of Growth LONG BEACH, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of Pedro Malha as President and Chief Executive Officer, effective October 1, 2025. He succeeds Marla Beck, who is stepping down as President and CEO effective September 30, 2025, and will remain in an advisory role. Brent Saunders, Chairman of the Board, stated, "Pedro is an accomplished leader with broad industry experience at lea

    9/30/25 4:30:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $AUVI
    $BCDA
    $HD
    $INVO
    Financials

    Live finance-specific insights

    View All

    The Home Depot to Host Fourth Quarter & Fiscal Year Earnings Conference Call on February 24

    ATLANTA, Feb. 10, 2026 /PRNewswire/ -- The Home Depot®, the world's largest home improvement retailer, announced today that it will hold its Fourth Quarter & Fiscal Year Earnings Conference Call on Tuesday, February 24, at 9 a.m. ET. A webcast will be available by logging onto http://ir.homedepot.com/events-and-presentations and selecting the Fourth Quarter Earnings Conference Call icon or directly at https://event.choruscall.com/mediaframe/webcast.html?webcastid=hLub2smn. The webcast will be archived, and the replay will be available beginning at approximately noon on Februar

    2/10/26 8:00:00 AM ET
    $HD
    RETAIL: Building Materials
    Consumer Discretionary

    The Home Depot Provides a Strategic Update; Reaffirms Fiscal 2025 Guidance; Establishes a Preliminary Fiscal 2026 Outlook and a Market Recovery Case

    ATLANTA, Dec. 9, 2025 /PRNewswire/ -- The Home Depot®, the world's largest home improvement retailer, will discuss key strategic priorities, provide a preliminary 2026 outlook and a market recovery case, today at its 2025 Investor and Analyst Conference.  Today's conference will begin at 8:30 a.m. ET and will be available in its entirety through a live webcast and replay at ir.homedepot.com/events-and-presentations. During today's conference, the company will discuss how it is uniquely positioned to grow market share and deliver shareholder value through its strategy to: drive

    12/9/25 6:00:00 AM ET
    $HD
    RETAIL: Building Materials
    Consumer Discretionary

    The Home Depot Declares Quarterly Dividend of $2.30

    ATLANTA, Nov. 20, 2025 /PRNewswire/ -- The Home Depot®, the world's largest home improvement retailer, today announced that its board of directors declared a quarterly cash dividend of $2.30 per share. The dividend is payable on December 18, 2025, to shareholders of record at the close of business on December 4, 2025. This is the 155th consecutive quarter the company has paid a cash dividend. The Home Depot is the world's largest home improvement specialty retailer.  At the end of the third quarter, the company operated a total of 2,356 retail stores and over 1,200 SRS locatio

    11/20/25 4:10:00 PM ET
    $HD
    RETAIL: Building Materials
    Consumer Discretionary